|
"shatin d"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T06:49:19Z |
Adverse events associated with prolonged antibiotic use
|
Meropol, S.B.;Chan, K.A.;Chen, Z.;Finkelstein, J.A.;Hennessy, S.;Lautenbach, E.;Platt, R.;Schech, S.D.;Shatin, D.;Metlay, J.P.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T06:14:04Z |
Risk factors for statin-associated rhabdomyolysis
|
Kin-Wei Chan; Schech, S.;Graham, D.;Staffa, J.;Andrade, S.E.;La Grenade, L.;Burgess, M.;Blough, D.;Stergachis, A.;Chan, K.A.;Platt, R.;Shatin, D. |
| 臺大學術典藏 |
2018-09-10T05:11:42Z |
Rhabdomyolysis and lipid-lowering drugs [2] (multiple letters)
|
Tenenbaum, A.;Fisman, E.Z.;Motro, M.;Graham, D.J.;Staffa, J.A.;La Grenade, L.;Shatin, D.;Schech, S.D.;Andrade, S.E.;Gurwitz, J.H.;Goodman, M.J.;Chan, K.A.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:11:41Z |
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis
|
Andrade, S.E.;Graham, D.J.;Staffa, J.A.;Schech, S.D.;Shatin, D.;La Grenade, L.;Goodman, M.J.;Platt, R.;Gurwitz, J.H.;Chan, K.A.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T04:43:20Z |
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
|
Graham, D.J.;Staffa, J.A.;Shatin, D.;Andrade, S.E.;Schech, S.D.;La Grenade, L.;Gurwitz, J.H.;Chan, K.A.;Goodman, M.J.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T03:23:50Z |
Contraindicated use cisapride: Impact of Food and Drug Administration regulatory action
|
Smalley, W.;Shatin, D.;Wysowski, D.K.;Gurwitz, J.;Andrade, S.E.;Goodman, M.;Chan, K.A.;Platt, R.;Schech, S.D.;Ray, W.A.; Kin-Wei Chan |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
